INDENTURE dated as of November 2, 2009 by and between QHP ROYALTY SUB LLC, a Delaware limited liability company, as issuer of the Notes described herein, and U.S. BANK NATIONAL ASSOCIATION, as initial trustee of the Notes described hereinIndenture • November 6th, 2009 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 6th, 2009 Company Industry JurisdictionThis INDENTURE, dated as of November 2, 2009, is by and between QHP ROYALTY SUB LLC, a Delaware limited liability company, as issuer of the Notes described herein, and U.S. BANK NATIONAL ASSOCIATION, a national banking association, as initial trustee of the Notes described herein.
PLEDGE AND SECURITY AGREEMENT MADE BY EACH UNDERSIGNED EQUITYHOLDER TO U.S. BANK NATIONAL ASSOCIATION, AS TRUSTEE DATED AS OF NOVEMBER 2, 2009Pledge and Security Agreement • November 6th, 2009 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 6th, 2009 Company Industry JurisdictionThis PLEDGE AND SECURITY AGREEMENT, dated as of November 2, 2009, is made by each undersigned Equityholder in favor of U.S. Bank National Association, a national banking association, as the Trustee under the Indenture, as grantee hereunder.
PURCHASE AND SALE AGREEMENT dated as of November 2, 2009 between PDL BIOPHARMA, INC. and QHP ROYALTY SUB LLCPurchase and Sale Agreement • November 6th, 2009 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 6th, 2009 Company Industry JurisdictionThis PURCHASE AND SALE AGREEMENT (this “Purchase and Sale Agreement”) dated as of November 2, 2009 is between PDL BIOPHARMA, INC., a Delaware corporation (“Seller”), and QHP ROYALTY SUB LLC, a Delaware limited liability company (“Purchaser”).
BILL OF SALEBill of Sale • November 6th, 2009 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledNovember 6th, 2009 Company Industry JurisdictionThis BILL OF SALE is dated as of November 2, 2009 (the “Closing Date”) by PDL BIOPHARMA, INC., a Delaware corporation (“Seller”), in favor of QHP ROYALTY SUB LLC, a Delaware limited liability company (“Purchaser”).